PIIND2023-04-012023-06-30 PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses03Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses04Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses05Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses06Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses07Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses08Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses09Member PIIND2023-04-012023-06-30in-bse-fin:OneOperatingExpenses10Member PIIND2023-06-30 PIIND2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2023-04-012023-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 523642 PIIND NOTLISTED PI Industries Limited Equity 2023-04-01 2024-03-31 2023-08-09 2023-07-31 INR Millions First quarter 14:30:00 19:50:00 2023-08-09 2023-08-09 Not applicable Single segment Agri 2023-04-01 2023-06-30 Unaudited Standalone 18292000000.00 471000000.00 18763000000.00 9166000000.00 601000000.00 116000000.00 1502000000.00 18000000.00 590000000.00 2155000000.00 14148000000.00 4615000000.00 0.00 4615000000.00 811000000.00 -149000000.00 662000000.00 0.00 3953000000.00 0.00 0.00 0.00 0.00 3953000000.00 302000000.00 4255000000.00 4255000000.00 0.00 152000000.00 1 26.06 26.06 0.00 0.00 26.06 26.06 1. The above financial results were reviewed and recommended by the Audit Committee of the Board and approved by the Board of Directors at their meeting held on August 09, 2023. 2. Financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies (Indian Accounting Standards) Rules, 2015. 3. The Figures for the quarter ended March 31, 2023 are the balancing figures between audited figures in respect of full financial year ended March 31, 2023 and the published unaudited year to date figures for the nine months period ended December 31, 2022. 4. The Company raised Rs. 20,000 million during the quarter ended 30th September 2020 through Qualified Institutional Placement (QIP) of equity shares. Out of the funds received of Rs. 19,750 million (net of expense of Rs. 250 million), the Company invested Rs. 8,430 million (including Rs. 865 million invested till March 31, 2023) in one of its subsidiary, Pl Health Sciences Limited. Balance funds of Rs. 11,320 million received pursuant to QIP remain invested in fixed deposits, liquid and other debt mutual funds. Advertisement & Sales Promotion 154000000.00 Environment & Pollution Control expenses 274000000.00 Freight & Cartage 167000000.00 Legal & professional fees 220000000.00 Others 545000000.00 Power, Fuel & Water 503000000.00 Provision for Bad and Doubtful debts & Advances 27000000.00 Repairs & Maintenance - Others 54000000.00 Repairs & Maintenance - Plant and machinery 58000000.00 Travelling and conveyance 153000000.00 Remeasurement gains/(losses) on defined benefits plans 7000000.00 7000000.00 2000000.00 Effective portion of gains /(losses) on cash flow hedges 457000000.00 457000000.00 160000000.00